Post-Marketing Surveillance on the Use of Prazaxa® (Japanese Prazaxa PMS, second)

25/05/2017
25/09/2026
EU PAS number:
EUPAS19283
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

1160-0284_CTP.pdf

English (319.55 KB - PDF) View document
Updated protocol

1160-0284_protocol_redacted.pdf

First published: 15/12/2025
English (319.55 KB - PDF) View document
Study results
Study results

1160-0284_Synopsis.pdf

English (518.88 KB - PDF) View document
Study report
Other information